Basiliximab Biosimilar - Research Grade

CD25

5mg/ml

Human IgG1 Kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

P01589;P01590

Blue ice

CD25, the interleukin-2 receptor alpha chain, is upregulated on activated and regulatory T cells, serving as a key marker across immunology and transplant research. This recombinant anti-human CD25 antibody is an unconjugated, non-therapeutic analog of basiliximab, supplied for research use only (RUO). It is manufactured to in vivo standards, presents low endotoxin, and is produced in scalable milligram (mg) to gram (g) quantities for bulk and high-throughput laboratories. It suits functional assays, IL-2 signalling and receptor-blockade studies, reproducible controls, and in vivo models of T-cell activation and tolerance, providing dependable consistency for high-volume work.

Detects human CD25

This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.